Factors for Treatment Failure After Fecal Microbiota Transplantation in Clostridioides difficile Infection
Author Information
Author(s): Park Soo-Hyun, Lee Jung-Hwan, Lee Suhjoon, Shin Jongbeom, Cha Boram, Hong Ji-Taek, Kwon Kye Sook
Primary Institution: Inha University Hospital
Hypothesis
What are the risk factors associated with treatment failure or recurrence after fecal microbiota transplantation for Clostridioides difficile infection?
Conclusion
Prolonged use of non-CDI antibiotics after fecal microbiota transplantation significantly increases the risk of treatment failure.
Supporting Evidence
- 75% of patients experienced symptom resolution within 7 days after FMT.
- 32.3% of patients experienced treatment failure.
- Prolonged use of non-CDI antibiotics after FMT was associated with a higher risk of treatment failure.
Takeaway
This study found that using certain antibiotics before and after a poop transplant can make it less likely to work for treating a gut infection.
Methodology
This retrospective cohort study analyzed data from patients who underwent fecal microbiota transplantation for CDI, assessing various risk factors for treatment failure.
Potential Biases
Potential selection bias due to the retrospective nature of the study and reliance on electronic medical records.
Limitations
The study's retrospective design may introduce selection bias, and it was conducted at a single institution, limiting generalizability.
Participant Demographics
Median age of participants was 75 years, with 47.6% male and 52.4% female.
Statistical Information
P-Value
p = 0.049 for males having a lower symptom improvement rate <7 days after FMT; p = 0.032 for antibiotic use after FMT.
Confidence Interval
95% CI: 1.92–9.63 for prolonged non-CDI antibiotics after FMT.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website